EXCRETION OF MECAMYLAMINE AFTER INTRAVENOUS AND ORAL ADMINISTRATION

被引:9
作者
ALLANBY, KD
TROUNCE, JR
机构
关键词
D O I
10.1136/bmj.2.5055.1219
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1219 / 1221
页数:3
相关论文
共 10 条
  • [1] RENAL ELIMINATION OF 3-METHYLAMINOISOCAMPHANE HYDROCHLORIDE (MECAMYLAMINE)
    BAER, JE
    PAULSON, SF
    RUSSO, HF
    BEYER, KH
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1956, 186 (01): : 180 - 186
  • [2] BRODIE BB, 1945, J BIOL CHEM, V158, P705
  • [3] DOYLE A E, 1955, Practitioner, V174, P135
  • [4] THE HYPOTENSIVE ACTION OF MECAMYLAMINE
    DOYLE, AE
    MURPHY, EA
    NEILSON, GH
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 1956, 2 (NOV24): : 1209 - 1211
  • [5] PHARMACOLOGY OF MECAMYLAMINE
    FORD, RV
    MADISON, JC
    MOYER, JH
    [J]. AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1956, 232 (02) : 129 - 143
  • [6] FREIS ED, 1955, LANCET, V2, P977
  • [7] HARINGTON M, 1953, CLIN SCI, V12, P185
  • [8] McMICHAEL J, 1955, J Chronic Dis, V1, P527, DOI 10.1016/0021-9681(55)90064-3
  • [9] MCQUEEN E G, 1956, Postgrad Med J, V32, P85
  • [10] USE OF MECAMYLAMINE IN THE MANAGEMENT OF HYPERTENSION
    SMIRK, FH
    MCQUEEN, EG
    [J]. BRITISH MEDICAL JOURNAL, 1957, 1 (FEB23) : 422 - 425